Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Business
Koch Invests In Pathway Biologic
by Melody M. Bomgardner
February 15, 2016
| A version of this story appeared in
Volume 94, Issue 7
Koch Biological Solutions, a subsidiary of Koch Industries, has taken an equity stake in Pathway Biologic, an agriculture start-up based in Plant City, Fla. Pathway develops plant growth promoters based on rhizobacteria. These root-zone inoculants, the firm claims, enhance soil health, optimize plant growth, and improve efficiency of water and fertilizer. Koch says it will collaborate with Pathway to bring new products to market. In 2014, Koch acquired the plant sciences firm Mendel Biotechnology.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter